Related Experiment Video
Updated: May 3, 2026

08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
16.2K
Dendron-functionalised hyperbranched bis-MPA polyesters as efficient non-viral vectors for gene therapy in different
María San Anselmo1, Alejandro Postigo1, Alexandre Lancelot1
1Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza, Spain. silviamh83@unizar.es.
Biomaterials Science
|April 20, 2022
Summary
New dendronized hyperbranched polymers (DHPs) show promise as non-viral vectors for gene therapy. These polymers effectively deliver genetic material into various cell types, including stem cells, for therapeutic applications.
Area of Science:
- Biomedical Engineering
- Polymer Chemistry
- Molecular Biology
Background:
- Gene therapy offers potential for treating and preventing diseases.
- Efficient delivery of genetic material into cells is critical for successful gene therapy.
- Non-viral vectors are being explored as safer alternatives to viral vectors.
Purpose of the Study:
- To design and evaluate amino-terminated dendronized hyperbranched polymers (DHPs) as non-viral gene delivery vectors.
- To assess the ability of DHPs to complex and deliver plasmid DNA and siRNA.
- To investigate the transfection efficiency of DHPs in various cell lines, including mesenchymal stem cells.
Main Methods:
- Synthesis of amino-terminated DHPs based on bis-MPA and bis-GMPA.
- Complexation of plasmid DNA and siGFP with DHPs to form dendriplexes.
- In vitro transfection studies using cancer cell lines and mesenchymal stem cells.
Main Results:
- DHPs effectively complexed both plasmid DNA and siGFP.
- Certain DHPs demonstrated efficient delivery of genetic material into cells.
- DHPs improved transfection activity compared to some commercial reagents.
- Successful transfection was observed in both cancer and mesenchymal stem cells.
Conclusions:
- Amino-terminated DHPs are effective non-viral vectors for gene delivery.
- DHPs show potential for genetic modification of mesenchymal stem cells, enhancing their therapeutic applications.
- Further development of DHPs could advance gene therapy strategies.

